Cuzzolin Laura, Zaccaron Ada, Fanos Vassilios
Department of Medicine and Public Health, University of Verona, Italy.
Fundam Clin Pharmacol. 2003 Feb;17(1):125-31. doi: 10.1046/j.1472-8206.2003.00123.x.
The off-label and unlicensed use of drugs to treat children is a common practice that occurs either in hospital or in the community. This derives from the fact that research for establishing drug efficacy and safety in children has not been carried out due to ethical problems, logistical difficulties, financial and legal concerns. In this work we report the studies available in literature documenting the extent of drug use in the paediatric field outside the recommendations of the license. From our analysis, a widespread attitude to prescribe medicines to children outside their product license either in the hospitals or in the community is confirmed. This suggests an immediate action for a more rationale use of drugs in paediatrics, to avoid exposing children and infants to unnecessary risks, but also to avoid depriving them of potentially effective and sometimes life-saving therapies.
药物用于儿童的超说明书和未获许可使用情况在医院或社区都很常见。这源于由于伦理问题、后勤困难、财务和法律问题,尚未开展确定药物在儿童中疗效和安全性的研究。在这项工作中,我们报告了文献中记录的超出许可建议范围的儿科领域药物使用情况的研究。通过我们的分析,证实了在医院或社区中给儿童开具超出其产品许可范围药物的普遍态度。这表明需要立即采取行动,在儿科更合理地使用药物,以避免让儿童和婴儿面临不必要的风险,同时也要避免剥夺他们获得潜在有效且有时能救命的治疗方法的机会。